Halberd Corporation (HALB)

OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0000 (-3.00%)
At close: Mar 6, 2026
-46.11%
Market Cap 1.09M
Revenue (ttm) 6.94K
Net Income (ttm) -1.71M
Shares Out 747.30M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,218,300
Average Volume 386,203
Open 0.0016
Previous Close 0.0015
Day's Range 0.0015 - 0.0016
52-Week Range 0.0011 - 0.0030
Beta 0.13
RSI 46.39
Earnings Date n/a

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol HALB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.